Needham Names MindMed (MNMD) New Top Pick for 2026, Adds to Conviction List
Tweet Send to a Friend
Needham analyst Ami Fadia reiterated a Hold rating and $28.00 price target on MindMed (NASDAQ: MNMD).The analyst comments "We highlight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
